19 Results

People

  1. Postow
    Postow
  2. Wolchok
    Wolchok
  3. Funt
    Funt
  4. Page
    Page
  5. Betof Warner
    Betof Warner
  6. Bourla
    Bourla
  7. Byun
    Byun
  8. Callahan
    Callahan
  9. Carvajal
    Carvajal
  10. Cattry
    Cattry

Groups

  1. Department of Medicine (14)
  2. Melanoma and Immunotherapeutics Service (12)
  3. Solid Tumor Oncology Division (12)
  4. GSK Faculty (8)
  5. Melanoma Disease Management Team (7)
  6. Hematologic Malignancies, Division of (3)
  7. Weinberg Fellows (3)
  8. Center for Hematologic Malignancies (2)
  9. Division of Subspecialty Medicine (2)
  10. Genitourinary Oncology Service (2)
  1. "advanced melanoma"
Formats
  1. Journal Article (17)
  2. Book Section (1)
  3. Guidelines (1)
Groups
  1. Department of Medicine (14)
  2. Melanoma and Immunotherapeutics Service (12)
  3. Solid Tumor Oncology Division (12)
  4. GSK Faculty (8)
  5. Melanoma Disease Management Team (7)
  6. Hematologic Malignancies, Division of (3)

More Groups

People
  1. Jedd Wolchok (8)
  2. Michael Postow (5)
  3. David Page (2)
  4. Margaret Callahan (2)
  5. Samuel Funt (2)
  6. Alexander Lesokhin (1)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (1)
  6. 2017 (3)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. European Journal of Cancer (4)
  3. Annals of Oncology (1)
  4. Cancer Treatment Reviews (1)
  5. Cell Research (1)
  6. Journal for ImmunoTherapy of Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. Elsevier Inc. (5)
  3. Nature Publishing Group (2)
  4. Biomed Central Ltd (1)
  5. C M P Medica LLC * The Oncology Group (1)
  6. Demos Medical Publications (1)

More Publishers

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients
    Journal Article

    Robert, C.; Long, G. V.; Larkin, J.; Wolchok, J. D.; Hassel, J. C.; Schadendorf, D.; Hodi, F. S.; Lebbé, C.; Grob, J. J.; Hyngstrom, J. R.; more...
    European Journal of Cancer (2025)

    Fulltext@MSK | Save
  • Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients
    Journal Article

    Betof Warner, A.; Tarhini, A.; Kang, B.; Nakasato, A.; Ling, Y. L.; Shah, R.; Tang, J.; Patel, J.
    Melanoma Research (2023)

    Fulltext@MSK | Save
  • Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update
    Guidelines

    Schneider, B. J.; Naidoo, J.; Santomasso, B. D.; Lacchetti, C.; Adkins, S.; Anadkat, M.; Atkins, M. B.; Brassil, K. J.; Caterino, J. M.; Chau, I.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma
    Journal Article

    Robert, C.; Hwu, W. J.; Hamid, O.; Ribas, A.; Weber, J. S.; Daud, A. I.; Hodi, F. S.; Wolchok, J. D.; Mitchell, T. C.; Hersey, P.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease
    Journal Article

    Abu-Sbeih, H.; Faleck, D. M.; Ricciuti, B.; Mendelsohn, R. B.; Naqash, A. R.; Cohen, J. V.; Sellers, M. C.; Balaji, A.; Ben-Betzalel, G.; Hajir, I.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Indications and toxicities of immune checkpoint inhibitor combinations
    Book Section

    Spain, L.; Postow, M. A.; Larkin, J.; Weber, J.
    In Ernstoff, M. S.; Puzanov, I.; Robert, C.; Diab, A.; Hersey, P. (Eds.) SITC's Guide to Managing Immunotherapy Toxicity (2019)

    Fulltext@MSK | Save
  • Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
    Journal Article

    Geoerger, B.; Bergeron, C.; Gore, L.; Sender, L.; Dunkel, I. J.; Herzog, C.; Brochez, L.; Cruz, O.; Nysom, K.; Berghorn, E.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Health-related quality of life results from the phase III CheckMate 067 study
    Journal Article

    Schadendorf, D.; Larkin, J.; Wolchok, J.; Hodi, F. S.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Cancer immunotherapy - Immune checkpoint blockade and associated endocrinopathies
    Journal Article

    Byun, D. J.; Wolchok, J. D.; Rosenberg, L. M.; Girotra, M.
    Nature Reviews Endocrinology (2017)

    Fulltext@MSK | Save
  • Phase III randomized trial of ipilimumab plus etoposide and platinum versus placebo plus etoposide and platinum in extensive-stage small-cell lung cancer
    Journal Article

    Reck, M.; Luft, A.; Szczesna, A.; Havel, L.; Kim, S. W.; Akerley, W.; Pietanza, M. C.; Wu, Y. L.; Zielinski, C.; Thomas, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save